GlassScriptPhysician profile
Ashok Mittal
NPI 1164496055
$1,411.08
in general payments reported to CMS, 2019-2025
20 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.90 · 2020: $103 · 2021: $167 · 2022: $408 · 2023: $333 · 2024: $196 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.04 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $508.53 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Abbott Laboratories | $260.92 | 2021-2023 | Mitraclip |
| Astrazeneca Pharmaceuticals LP | $206.37 | 2020-2023 | Imfinzi |
| Intuitive Surgical, INC. | $65.37 | 2024 | |
| Merck Sharp & Dohme LLC | $60.39 | 2021-2022 | |
| Amgen INC. | $55.99 | 2022-2025 | |
| Genzyme Corporation | $42.07 | 2019-2022 | |
| Apria Healthcare LLC | $32.19 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.75 | 2022 | |
| Genentech USA, INC. | $19.57 | 2021 | |
| Phadia US INC. | $18.30 | 2025 | Immunocap |
| Pfizer INC. | $16.93 | 2020 | |
| Philips North America LLC | $15.28 | 2022 | |
| 3b Medical, INC. | $14.69 | 2023 | Luna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.22 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.00 | 2019 | |
| Harmony Biosciences LLC | $13.65 | 2022 | |
| Insmed, INC. | $11.43 | 2019 | |
| Mylan Specialty L.P. | $10.92 | 2019 | |
| Inogen, INC. | $3.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Mittal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.